Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway

Oncogene
E J ChapmanM A Knowles

Abstract

The CDKN2A locus is frequently inactivated in urothelial cell carcinoma (UCC), yet how this alteration contributes to bladder tumorigenesis is not known. Although most UCC express telomerase, inactivation of the p16/Rb pathway is generally required for in vitro immortalisation. This and the involvement of p16 in senescence of normal human urothelial cells (NHUC) suggest that CDKN2A deletion may aid bypass of senescence and allow immortalisation. CDKN2A encodes p16 and p14ARF and therefore inactivation of this locus can disrupt both the Rb and p53 tumour suppressor pathways. Retrovirus-mediated transduction was used to specifically modulate the p16/Rb and/or p53 tumour suppressor pathways in NHUC and to express human telomerase reverse transcriptase (hTERT). Expression of hTERT bypassed Rb and p53 pathway-dependent barriers to proliferation and immortalised NHUC. TERT-NHUC had normal karyotypes, were non-tumorigenic and unexpectedly retained CDKN2A. Thus, the phenotypic significance of inactivation of CDKN2A in UCC may not be solely related to bypass of senescence. Phenotypic assays in human urothelial cells have relied on cell strains derived from invasive tumours or NHUC immortalised by expression of SV40-large T. The producti...Continue Reading

References

Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·D E WazerV Band
Aug 1, 1993·The Journal of Urology·K A HuttonJ Southgate
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·D A AlcortaJ C Barrett
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·C D BelairC A Reznikoff
Mar 7, 1998·Genes & Development·T R YeagerC A Reznikoff
Sep 3, 1999·The Journal of Biological Chemistry·J YangG S Herron
Dec 22, 1999·Advances in Experimental Medicine and Biology·J A PuthenveettilC A Reznikoff
May 4, 2000·The American Journal of Pathology·D G FarwellA J Klingelhutz
Feb 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·M J O'HareP S Jat
Jun 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·R M AlaniC B Shifflett
Jul 31, 2001·Molecular Pathology : MP·M A Knowles
Jan 16, 2002·Current Opinion in Genetics & Development·Sarah Drayton, Gordon Peters
Jul 9, 2002·The Journal of Biological Chemistry·Lynne W ElmoreShawn E Holt
Aug 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sheila A StewartRobert A Weinberg
Feb 8, 2003·Current Opinion in Genetics & Development·Scott W Lowe, Charles J Sherr
Apr 30, 2003·Nature Cell Biology·Laura L SmithJames M Roberts
Dec 21, 2004·Oncogene·Rubaiyat RahmanKlas G Wiman
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Emma J ChapmanMargaret A Knowles

❮ Previous
Next ❯

Citations

Dec 8, 2010·In Vitro Cellular & Developmental Biology. Animal·Jayoung KimRosalyn M Adam
Jun 7, 2012·Cellular Oncology (Dordrecht)·Annemarie KochWolfgang A Schulz
Aug 15, 2012·Tissue Engineering. Part C, Methods·Praveen K SobhanM Radhakrishna Pillai
Apr 10, 2008·Human Molecular Genetics·Louis S PymarMargaret A Knowles
Nov 24, 2012·Human Molecular Genetics·Sarah V WilliamsMargaret A Knowles
Oct 22, 2009·Cancer Research·James W F CattoFreddie C Hamdy
Jul 11, 2008·Expert Opinion on Biological Therapy·Fiona Bolland, Jennifer Southgate
Mar 1, 2011·European Urology·Nikolaos T GeorgopoulosJennifer Southgate
Feb 9, 2010·Biochemical and Biophysical Research Communications·Chun-Liang TungChin Li
Jul 25, 2009·Molecular Carcinogenesis·Emma J Chapman, Margaret A Knowles
Oct 22, 2008·Journal of Cellular Physiology·Chih-Chiang ChienYen-Chou Chen
Mar 6, 2008·Journal of Cellular and Molecular Medicine·Wolfgang BöckerMatthias Schieker
May 4, 2012·BJU International·Peter OchodnickýMartin C Michel
Feb 27, 2010·Cellular & Molecular Biology Letters·Michelle SchmidtJaideep Chaudhary
Jun 28, 2011·The American Journal of Pathology·Matthew D NitzDan Theodorescu
Jul 28, 2017·PloS One·Olof HerttingAnnelie Brauner
Feb 2, 2018·Scientific Reports·Atsushi SengikuHiromitsu Negoro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.